Covered skin transcutaneous bilirubin estimation is comparable with serum bilirubin during and after phototherapy

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Objective:To determine whether transcutaneous bilirubin (TcB) from covered skin (TcB-C) during and after discontinuing phototherapy (PHT) is reliable in treating neonatal jaundice. Study Design:In this prospective observational study, before starting PHT, part of the forehead was covered. TcB-C and TcB from exposed skin (TcB-E) to PHT were measured before starting PHT, on a 12-hourly basis while receiving PHT and 6 h after stopping PHT. We used ANOVA (analysis of variance) and Bonferroni's t-tests. Result:A total of 39 infants were enrolled (mean gestation 39 weeks, 51% males and 80% Hispanic). The mean TSB over all time periods was 10.9 ± 2.4, TcB-C 10.9 ± 2.4 and TcB-E 7.2 ± 3.4. Before PHT, there were no significant differences in bilirubin by all three techniques. TcB-C was not significantly different from TSB at any time point. However, TcB-E was significantly lower during PHT and after stopping PHT. Conclusion:TcB-C is a reliable method in the management of neonatal jaundice.

Original languageEnglish (US)
Pages (from-to)129-131
Number of pages3
JournalJournal of Perinatology
Volume32
Issue number2
DOIs
StatePublished - Feb 2012

Fingerprint

Phototherapy
Bilirubin
Skin
Serum
Neonatal Jaundice
Forehead
Hispanic Americans
Observational Studies
Analysis of Variance
Prospective Studies

Keywords

  • covered skin transcutaneous bilirubin
  • phototherapy
  • serum bilirubin
  • transcutaneous bilirubin

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Pediatrics, Perinatology, and Child Health

Cite this

@article{77f2a17bbc8e45579b2d332328f5ef68,
title = "Covered skin transcutaneous bilirubin estimation is comparable with serum bilirubin during and after phototherapy",
abstract = "Objective:To determine whether transcutaneous bilirubin (TcB) from covered skin (TcB-C) during and after discontinuing phototherapy (PHT) is reliable in treating neonatal jaundice. Study Design:In this prospective observational study, before starting PHT, part of the forehead was covered. TcB-C and TcB from exposed skin (TcB-E) to PHT were measured before starting PHT, on a 12-hourly basis while receiving PHT and 6 h after stopping PHT. We used ANOVA (analysis of variance) and Bonferroni's t-tests. Result:A total of 39 infants were enrolled (mean gestation 39 weeks, 51{\%} males and 80{\%} Hispanic). The mean TSB over all time periods was 10.9 ± 2.4, TcB-C 10.9 ± 2.4 and TcB-E 7.2 ± 3.4. Before PHT, there were no significant differences in bilirubin by all three techniques. TcB-C was not significantly different from TSB at any time point. However, TcB-E was significantly lower during PHT and after stopping PHT. Conclusion:TcB-C is a reliable method in the management of neonatal jaundice.",
keywords = "covered skin transcutaneous bilirubin, phototherapy, serum bilirubin, transcutaneous bilirubin",
author = "Rafael Fonseca and R. Kyralessa and Michael Malloy and Carol Richardson and Sunil Jain",
year = "2012",
month = "2",
doi = "10.1038/jp.2011.66",
language = "English (US)",
volume = "32",
pages = "129--131",
journal = "Journal of Perinatology",
issn = "0743-8346",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Covered skin transcutaneous bilirubin estimation is comparable with serum bilirubin during and after phototherapy

AU - Fonseca, Rafael

AU - Kyralessa, R.

AU - Malloy, Michael

AU - Richardson, Carol

AU - Jain, Sunil

PY - 2012/2

Y1 - 2012/2

N2 - Objective:To determine whether transcutaneous bilirubin (TcB) from covered skin (TcB-C) during and after discontinuing phototherapy (PHT) is reliable in treating neonatal jaundice. Study Design:In this prospective observational study, before starting PHT, part of the forehead was covered. TcB-C and TcB from exposed skin (TcB-E) to PHT were measured before starting PHT, on a 12-hourly basis while receiving PHT and 6 h after stopping PHT. We used ANOVA (analysis of variance) and Bonferroni's t-tests. Result:A total of 39 infants were enrolled (mean gestation 39 weeks, 51% males and 80% Hispanic). The mean TSB over all time periods was 10.9 ± 2.4, TcB-C 10.9 ± 2.4 and TcB-E 7.2 ± 3.4. Before PHT, there were no significant differences in bilirubin by all three techniques. TcB-C was not significantly different from TSB at any time point. However, TcB-E was significantly lower during PHT and after stopping PHT. Conclusion:TcB-C is a reliable method in the management of neonatal jaundice.

AB - Objective:To determine whether transcutaneous bilirubin (TcB) from covered skin (TcB-C) during and after discontinuing phototherapy (PHT) is reliable in treating neonatal jaundice. Study Design:In this prospective observational study, before starting PHT, part of the forehead was covered. TcB-C and TcB from exposed skin (TcB-E) to PHT were measured before starting PHT, on a 12-hourly basis while receiving PHT and 6 h after stopping PHT. We used ANOVA (analysis of variance) and Bonferroni's t-tests. Result:A total of 39 infants were enrolled (mean gestation 39 weeks, 51% males and 80% Hispanic). The mean TSB over all time periods was 10.9 ± 2.4, TcB-C 10.9 ± 2.4 and TcB-E 7.2 ± 3.4. Before PHT, there were no significant differences in bilirubin by all three techniques. TcB-C was not significantly different from TSB at any time point. However, TcB-E was significantly lower during PHT and after stopping PHT. Conclusion:TcB-C is a reliable method in the management of neonatal jaundice.

KW - covered skin transcutaneous bilirubin

KW - phototherapy

KW - serum bilirubin

KW - transcutaneous bilirubin

UR - http://www.scopus.com/inward/record.url?scp=84856594008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856594008&partnerID=8YFLogxK

U2 - 10.1038/jp.2011.66

DO - 10.1038/jp.2011.66

M3 - Article

C2 - 21818063

AN - SCOPUS:84856594008

VL - 32

SP - 129

EP - 131

JO - Journal of Perinatology

JF - Journal of Perinatology

SN - 0743-8346

IS - 2

ER -